Coronary heart disease secondary prevention smoking cessation: Difference between revisions
Jump to navigation
Jump to search
Esther Lee (talk | contribs) (Created page with "__NOTOC__ {{Coronary heart disease}} {{CMG}} == Overview == == Smoking Cessation == === AHA / ACC 2012 Guidelines - Coronary Heart disease - Secondary Prevention for Patient...") |
|||
(6 intermediate revisions by 3 users not shown) | |||
Line 3: | Line 3: | ||
{{CMG}} | {{CMG}} | ||
== | ==2011 AHA/ACCF Guidelines for Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease (DO NOT EDIT) <ref name="pmid22052934">{{cite journal| author=Smith SC, Benjamin EJ, Bonow RO, Braun LT, Creager MA, Franklin BA et al.| title=AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. | journal=Circulation | year= 2011 | volume= 124 | issue= 22 | pages= 2458-73 | pmid=22052934 | doi=10.1161/CIR.0b013e318235eb4d | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22052934 }} </ref>== | ||
== | |||
=== | ===Smoking Cessation (DO NOT EDIT) <ref name="pmid22052934">{{cite journal| author=Smith SC, Benjamin EJ, Bonow RO, Braun LT, Creager MA, Franklin BA et al.| title=AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. | journal=Circulation | year= 2011 | volume= 124 | issue= 22 | pages= 2458-73 | pmid=22052934 | doi=10.1161/CIR.0b013e318235eb4d | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22052934 }} </ref>=== | ||
{{cquote|Goal: Complete cessation. No exposure to environmental tobacco smoke.}} | |||
{|class="wikitable" | {|class="wikitable" | ||
|- | |- | ||
Line 15: | Line 13: | ||
|- | |- | ||
| bgcolor="LightGreen"|<nowiki>"</nowiki>'''1.''' Patients should be asked about tobacco use status at every office visit. ([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: B]]) <nowiki>"</nowiki> | | bgcolor="LightGreen"|<nowiki>"</nowiki>'''1.''' Patients should be asked about tobacco use status at every office visit. <ref name="pmid18195316">{{cite journal |author=Rothemich SF, Woolf SH, Johnson RE, ''et al.'' |title=Effect on cessation counseling of documenting smoking status as a routine vital sign: an ACORN study |journal=Ann Fam Med |volume=6 |issue=1 |pages=60–8 |year=2008 |pmid=18195316 |pmc=2203392 |doi=10.1370/afm.750 |url=}}</ref><ref name="pmid21221363">{{cite journal |author=Rosser W, McDowell I, Newell C |title=Documenting smoking Status: Trial of three strategies |journal=Can Fam Physician |volume=38 |issue= |pages=1623–8 |year=1992 |month=July |pmid=21221363 |pmc=2146014 |doi= |url=}}</ref><ref name="urlSystems Change: Treating Tobacco Use and Dependence">{{cite web |url=http://www.ahrq.gov/clinic/tobacco/systems.htm |title=Systems Change: Treating Tobacco Use and Dependence |format= |work= |accessdate=}}</ref><ref name="pmid2930094">{{cite journal |author=Cummings SR, Coates TJ, Richard RJ, ''et al.'' |title=Training physicians in counseling about smoking cessation. A randomized trial of the "Quit for Life" program |journal=Ann. Intern. Med. |volume=110 |issue=8 |pages=640–7 |year=1989 |month=April |pmid=2930094 |doi= |url=}}</ref><ref name="urlwww.surgeongeneral.gov">{{cite web |url=http://www.surgeongeneral.gov/tobacco/treating_tobacco_use08.pdf.+ |title=www.surgeongeneral.gov |format= |work= |accessdate=}}</ref> ([[ACC AHA guidelines classification scheme#Level of Evidence|''Level of Evidence: B'']]) <nowiki>"</nowiki> | ||
|- | |- | ||
| bgcolor="LightGreen"|<nowiki>"</nowiki>'''2.''' Every tobacco user should be advised at every visit to quit. ([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: A]]) <nowiki>"</nowiki> | | bgcolor="LightGreen"|<nowiki>"</nowiki>'''2.''' Every tobacco user should be advised at every visit to quit. <ref name="urlSystems Change: Treating Tobacco Use and Dependence">{{cite web |url=http://www.ahrq.gov/clinic/tobacco/systems.htm |title=Systems Change: Treating Tobacco Use and Dependence |format= |work= |accessdate=}}</ref><ref name="pmid2930094">{{cite journal |author=Cummings SR, Coates TJ, Richard RJ, ''et al.'' |title=Training physicians in counseling about smoking cessation. A randomized trial of the "Quit for Life" program |journal=Ann. Intern. Med. |volume=110 |issue=8 |pages=640–7 |year=1989 |month=April |pmid=2930094 |doi= |url=}}</ref><ref name="urlwww.surgeongeneral.gov">{{cite web |url=http://www.surgeongeneral.gov/tobacco/treating_tobacco_use08.pdf.+ |title=www.surgeongeneral.gov |format= |work= |accessdate=}}</ref><ref name="pmid15710956">{{cite journal |author=Anthonisen NR, Skeans MA, Wise RA, Manfreda J, Kanner RE, Connett JE |title=The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial |journal=Ann. Intern. Med. |volume=142 |issue=4 |pages=233–9 |year=2005 |month=February |pmid=15710956 |doi= |url=}}</ref> ([[ACC AHA guidelines classification scheme#Level of Evidence|''Level of Evidence: A'']]) <nowiki>"</nowiki> | ||
|- | |- | ||
| bgcolor="LightGreen"|<nowiki>"</nowiki>'''3.''' The tobacco user's willingness to quit should be assessed at every visit. ([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: C]]) <nowiki>"</nowiki> | | bgcolor="LightGreen"|<nowiki>"</nowiki>'''3.''' The tobacco user's willingness to quit should be assessed at every visit. ([[ACC AHA guidelines classification scheme#Level of Evidence|''Level of Evidence: C'']]) <nowiki>"</nowiki> | ||
|- | |- | ||
| bgcolor="LightGreen"|<nowiki>"</nowiki>'''4.''' Patients should be assisted by counseling and by development of a plan for quitting that may include pharmacotherapy and/or referral to a smoking cessation program. ([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: A]]) <nowiki>"</nowiki> | | bgcolor="LightGreen"|<nowiki>"</nowiki>'''4.''' Patients should be assisted by counseling and by development of a plan for quitting that may include pharmacotherapy and/or referral to a smoking cessation program. <ref name="urlSystems Change: Treating Tobacco Use and Dependence">{{cite web |url=http://www.ahrq.gov/clinic/tobacco/systems.htm |title=Systems Change: Treating Tobacco Use and Dependence |format= |work= |accessdate=}}</ref><ref name="pmid2930094">{{cite journal |author=Cummings SR, Coates TJ, Richard RJ, ''et al.'' |title=Training physicians in counseling about smoking cessation. A randomized trial of the "Quit for Life" program |journal=Ann. Intern. Med. |volume=110 |issue=8 |pages=640–7 |year=1989 |month=April |pmid=2930094 |doi= |url=}}</ref><ref name="pmid2685206">{{cite journal |author=Cummings SR, Richard RJ, Duncan CL, ''et al.'' |title=Training physicians about smoking cessation: a controlled trial in private practice |journal=J Gen Intern Med |volume=4 |issue=6 |pages=482–9 |year=1989 |pmid=2685206 |doi= |url=}}</ref><ref name="urlwww.surgeongeneral.gov">{{cite web |url=http://www.surgeongeneral.gov/tobacco/treating_tobacco_use08.pdf.+ |title=www.surgeongeneral.gov |format= |work= |accessdate=}}</ref><ref name="pmid2053669">{{cite journal |author=Duncan C, Stein MJ, Cummings SR |title=Staff involvement and special follow-up time increase physicians' counseling about smoking cessation: a controlled trial |journal=Am J Public Health |volume=81 |issue=7 |pages=899–901 |year=1991 |month=July |pmid=2053669 |pmc=1405179 |doi= |url=}}</ref><ref name="pmid15710956">{{cite journal |author=Anthonisen NR, Skeans MA, Wise RA, Manfreda J, Kanner RE, Connett JE |title=The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial |journal=Ann. Intern. Med. |volume=142 |issue=4 |pages=233–9 |year=2005 |month=February |pmid=15710956 |doi= |url=}}</ref> ([[ACC AHA guidelines classification scheme#Level of Evidence|''Level of Evidence: A'']]) <nowiki>"</nowiki> | ||
|- | |- | ||
| bgcolor="LightGreen"|<nowiki>"</nowiki>'''5.''' Arrangement for follow up is recommended. ([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: C]]) <nowiki>"</nowiki> | | bgcolor="LightGreen"|<nowiki>"</nowiki>'''5.''' Arrangement for follow up is recommended. ([[ACC AHA guidelines classification scheme#Level of Evidence|''Level of Evidence: C'']]) <nowiki>"</nowiki> | ||
|- | |- | ||
| bgcolor="LightGreen"|<nowiki>"</nowiki>'''6.''' All patients should be advised at every office visit to avoid exposure to environmental tobacco smoke at work, home, and public places. ([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: B]]) <nowiki>"</nowiki> | | bgcolor="LightGreen"|<nowiki>"</nowiki>'''6.''' All patients should be advised at every office visit to avoid exposure to environmental tobacco smoke at work, home, and public places. <ref name="isbn0-16-076152-2">{{cite book |author= |title=The health consequences of involuntary exposure to tobacco smoke: a report of the Surgeon General |publisher=U.S. Dept. of Health and Human Services, Public Health Service, Office of the Surgeon General |location=Rockville, MD |year=2006 |pages= |isbn=0-16-076152-2 |oclc= |doi= |accessdate=}}</ref><ref name="isbn0-309-13839-6">{{cite book |author=Institute of Medicine; Committee on Secondhand Smoke Exposure and Acute Coronary Events |title=Secondhand Smoke Exposure and Cardiovascular Effects: Making Sense of the Evidence |publisher=National Academies Press |location=Washington, D.C |year=2010 |pages= |isbn=0-309-13839-6 |oclc= |doi= |accessdate=}}</ref> ([[ACC AHA guidelines classification scheme#Level of Evidence|''Level of Evidence: B'']]) <nowiki>"</nowiki> | ||
|} | |} | ||
Line 40: | Line 38: | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Needs overview]] | |||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Cardiology]] | [[Category:Cardiology]] |
Latest revision as of 14:17, 11 January 2013
Coronary heart disease Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Coronary heart disease secondary prevention smoking cessation On the Web |
American Roentgen Ray Society Images of Coronary heart disease secondary prevention smoking cessation |
FDA on Coronary heart disease secondary prevention smoking cessation |
CDC on Coronary heart disease secondary prevention smoking cessation |
Coronary heart disease secondary prevention smoking cessation in the news |
Blogs on Coronary heart disease secondary prevention smoking cessation |
Risk calculators and risk factors for Coronary heart disease secondary prevention smoking cessation |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
2011 AHA/ACCF Guidelines for Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease (DO NOT EDIT) [1]
Smoking Cessation (DO NOT EDIT) [1]
“ | Goal: Complete cessation. No exposure to environmental tobacco smoke. | ” |
Class I |
"1. Patients should be asked about tobacco use status at every office visit. [2][3][4][5][6] (Level of Evidence: B) " |
"2. Every tobacco user should be advised at every visit to quit. [4][5][6][7] (Level of Evidence: A) " |
"3. The tobacco user's willingness to quit should be assessed at every visit. (Level of Evidence: C) " |
"4. Patients should be assisted by counseling and by development of a plan for quitting that may include pharmacotherapy and/or referral to a smoking cessation program. [4][5][8][6][9][7] (Level of Evidence: A) " |
"5. Arrangement for follow up is recommended. (Level of Evidence: C) " |
"6. All patients should be advised at every office visit to avoid exposure to environmental tobacco smoke at work, home, and public places. [10][11] (Level of Evidence: B) " |
References
- ↑ 1.0 1.1 Smith SC, Benjamin EJ, Bonow RO, Braun LT, Creager MA, Franklin BA; et al. (2011). "AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation". Circulation. 124 (22): 2458–73. doi:10.1161/CIR.0b013e318235eb4d. PMID 22052934.
- ↑ Rothemich SF, Woolf SH, Johnson RE; et al. (2008). "Effect on cessation counseling of documenting smoking status as a routine vital sign: an ACORN study". Ann Fam Med. 6 (1): 60–8. doi:10.1370/afm.750. PMC 2203392. PMID 18195316.
- ↑ Rosser W, McDowell I, Newell C (1992). "Documenting smoking Status: Trial of three strategies". Can Fam Physician. 38: 1623–8. PMC 2146014. PMID 21221363. Unknown parameter
|month=
ignored (help) - ↑ 4.0 4.1 4.2 "Systems Change: Treating Tobacco Use and Dependence".
- ↑ 5.0 5.1 5.2 Cummings SR, Coates TJ, Richard RJ; et al. (1989). "Training physicians in counseling about smoking cessation. A randomized trial of the "Quit for Life" program". Ann. Intern. Med. 110 (8): 640–7. PMID 2930094. Unknown parameter
|month=
ignored (help) - ↑ 6.0 6.1 6.2 "www.surgeongeneral.gov".
- ↑ 7.0 7.1 Anthonisen NR, Skeans MA, Wise RA, Manfreda J, Kanner RE, Connett JE (2005). "The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial". Ann. Intern. Med. 142 (4): 233–9. PMID 15710956. Unknown parameter
|month=
ignored (help) - ↑ Cummings SR, Richard RJ, Duncan CL; et al. (1989). "Training physicians about smoking cessation: a controlled trial in private practice". J Gen Intern Med. 4 (6): 482–9. PMID 2685206.
- ↑ Duncan C, Stein MJ, Cummings SR (1991). "Staff involvement and special follow-up time increase physicians' counseling about smoking cessation: a controlled trial". Am J Public Health. 81 (7): 899–901. PMC 1405179. PMID 2053669. Unknown parameter
|month=
ignored (help) - ↑ The health consequences of involuntary exposure to tobacco smoke: a report of the Surgeon General. Rockville, MD: U.S. Dept. of Health and Human Services, Public Health Service, Office of the Surgeon General. 2006. ISBN 0-16-076152-2.
- ↑ Institute of Medicine; Committee on Secondhand Smoke Exposure and Acute Coronary Events (2010). Secondhand Smoke Exposure and Cardiovascular Effects: Making Sense of the Evidence. Washington, D.C: National Academies Press. ISBN 0-309-13839-6.